Application of a New Subretinal Injection Device in the Dog

Simple item page
dc.contributor.authorKomáromy, András M
dc.contributor.authorKomáromy, András M
dc.contributor.authorVarner, Signe E
dc.contributor.authorde Juan, Eugene
dc.contributor.authorAcland, Gregory M
dc.contributor.authorAguirre, Gustavo D
dc.date2023-05-17T07:56:33.000
dc.date.accessioned2023-05-23T04:45:08Z
dc.date.available2023-05-23T04:45:08Z
dc.date.issued2006-06-01
dc.date.submitted2013-08-20T14:02:13-07:00
dc.description.abstractThe use of a new subretinal injection device (RetinaJect™ Subretinal Cannula, SurModics, Inc., Eden Prairie, MN) to access the subretinal space in the canine model was evaluated. Subretinal injections were performed in 33 mongrel dogs between 2 and 52 months of age (median = 9 months). In 5 normal dogs the injection of 150 μl saline or India ink occurred by using a conventional subretinal injection device (CSID) with a 30-gauge anterior chamber irrigating cannula. The sclera had to be surgically exposed and penetrated before the subretinal injection with the CSID could occur. After removing the CSID, the conjunctiva over the sclerotomy site had to be closed. In a second group of 28 dogs [16 normals, 10 RPE65 mutants, and 2 with progressive rod cone degeneration (prcd)], the 25-gauge needle of the RetinaJect™ was used to penetrate the conjunctiva and the sclera. Once the tip of the needle was close to the retinal surface, a 39-gauge polyimide cannula was extended and brought into apposition with the retina for the subsequent subretinal injection of 150 μl saline, India ink, or adeno-associated virus (AAV). No closure of the conjunctiva was required. The animals were clinically monitored between 1 and 59 weeks after surgery. From this second group 25 eyes were harvested for routine histological analysis either immediately after surgery or after a clinical observation time of between 1 and 40 weeks. Both devices provided equally successful access to the subretinal space. The main advantage of the RetinaJect™ was that no surgical dissection was required; this led to a shorter procedure time and milder postoperative conjunctival swelling. In summary, the use of the RetinaJect™ can be recommended as an alternative to the CSID for subretinal injections in dogs.
dc.identifier.urihttps://repository.upenn.edu/handle/20.500.14332/48941
dc.legacy.articleid1025
dc.legacy.fieldstrue
dc.legacy.fields10.3727/000000006783981701
dc.legacy.fulltexturlhttps://repository.upenn.edu/cgi/viewcontent.cgi?article=1025&context=vet_papers&unstamped=1
dc.rightsCopyright © 2006 Cognizant Comm. Corp. www.cognizantcommunication.com
dc.source.beginpage511
dc.source.endpage519
dc.source.issue26
dc.source.issue6
dc.source.journalDepartmental Papers (Vet)
dc.source.journaltitleCell Transplantation
dc.source.peerreviewedtrue
dc.source.statuspublished
dc.source.volume15
dc.subject.otheranimal model
dc.subject.otherdog
dc.subject.otherretinitis pigmentosa
dc.subject.othersubretinal injection
dc.subject.otherMedicine and Health Sciences
dc.subject.otherOphthalmology
dc.subject.otherVeterinary Medicine
dc.titleApplication of a New Subretinal Injection Device in the Dog
dc.typeArticle
digcom.contributor.authorisAuthorOfPublication|email:komaromy@vet.upenn.edu|institution:University of Pennsylvania|Komáromy, András M
digcom.contributor.authorVarner, Signe E
digcom.contributor.authorde Juan, Eugene
digcom.contributor.authorAcland, Gregory M
digcom.contributor.authorAguirre, Gustavo D
digcom.identifiervet_papers/26
digcom.identifier.contextkey4470950
digcom.identifier.submissionpathvet_papers/26
digcom.typearticle
dspace.entity.typePublication
relation.isAuthorOfPublicationaa08ea8a-6ab2-4246-9254-2e8cdccf7bcd
relation.isAuthorOfPublication.latestForDiscoveryaa08ea8a-6ab2-4246-9254-2e8cdccf7bcd
upenn.schoolDepartmentCenterDepartmental Papers (Vet)
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
application_of_a_new_subretinal.pdf
Size:
315.28 KB
Format:
Adobe Portable Document Format
Download
Collection
Articles